RankAlpha logo
Back to Rankings

KLRA

Kailera TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
KLRA vs peer average
24/100
KLRA vs. peer average (F vs. C)
Grade spread
A 2 · B 1 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

CDNA is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $2.4B

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCDNACareDx
KLRA
Kailera Therapeutics
CDNA
CareDx
Grade
F
F
Momentum
4
98
Value
46
58
Sentiment
-
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs CDNA

KLRA / CDNA
Grade Position
Below peers
KLRA vs. peer average (F vs. C)
24/100
Momentum
4
CDNA
Value
46
CDNA
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs KLRA
1
CDNA
CareDx Inc Common
F
20/100
Even
2
URGN
UroGen Pharma Ltd Common
F
20/100
Even
3
AMLX
Amylyx Pharmaceuticals Inc Common
D
40/100
-1
4
PBH
Prestige Consumer Healthcare Inc Common
A
100/100
-4
5
PGEN
Precigen Inc Common
F
20/100
Even
CDNA is the first peer returned for this comparison set.